Ella Nkhoma

Regeneron Pharmaceuticals, Inc.

Poster(s):

• (B-008) Comparing approaches to real-world progression-free survival estimation among patients with advanced melanoma on first-line immunotherapy
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (B-188) Safety and Effectiveness of Cemiplimab in Combination with Platinum-Doublet Chemotherapy by Demographic Characteristics in First-Line Treatment of Advanced Non-Small Cell Lung Cancer: An Ongoing Real World Evidence Study
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET